Literature DB >> 23447733

Zonisamide should be considered a first-line antiepileptic drug for patients with newly diagnosed partial epilepsy.

Alison M Pack.   

Abstract

Entities:  

Year:  2013        PMID： 23447733      PMCID： PMC3577080          DOI： 10.5698/1535-7511-13.1.22

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.

Authors:  Patrick Kwan; Martin J Brodie; Reetta Kälviäinen; Lorraine Yurkewicz; Jerry Weaver; Lloyd E Knapp
Journal:  Lancet Neurol       Date:  2011-08-31       Impact factor: 44.182

Review 2.  ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Authors:  Tracy Glauser; Elinor Ben-Menachem; Blaise Bourgeois; Avital Cnaan; David Chadwick; Carlos Guerreiro; Reetta Kalviainen; Richard Mattson; Emilio Perucca; Torbjorn Tomson
Journal:  Epilepsia       Date:  2006-07       Impact factor: 5.864

3.  New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.

Authors:  A J Rowan; R E Ramsay; J F Collins; F Pryor; K D Boardman; B M Uthman; M Spitz; T Frederick; A Towne; G S Carter; W Marks; J Felicetta; M L Tomyanovich
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

4.  Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

Authors:  Michel Baulac; Martin J Brodie; Anna Patten; Joanna Segieth; Luigi Giorgi
Journal:  Lancet Neurol       Date:  2012-06-08       Impact factor: 44.182

5.  Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.

Authors:  M J Brodie; E Perucca; P Ryvlin; E Ben-Menachem; H-J Meencke
Journal:  Neurology       Date:  2007-02-06       Impact factor: 9.910

6.  The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.